Skip to Main Content

Author Details

Jianying Zhang
City of Hope National Medical Center
2009
90
40
PMIDPaper TitleJournal TitlePublished Year
34668775The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.J Virol2022
34645647Targeting Fc Receptor-Mediated Effects and the "Don't Eat Me" Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer.Clin Cancer Res2022
33419766Cbl-b Is Upregulated and Plays a Negative Role in Activated Human NK Cells.J Immunol2021
33659005A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis.Front Immunol2021
34625564An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma.Nat Commun2021
34160549The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.J Exp Med2021
34326137Hijacking TYRO3 from Tumor Cells via Trogocytosis Enhances NK-cell Effector Functions and Proliferation.Cancer Immunol Res2021
34127971Dual roles of a novel oncolytic viral vector-based SARS-CoV-2 vaccine: preventing COVID-19 and treating tumor progression.bioRxiv2021
34127969FXa cleaves the SARS-CoV-2 spike protein and blocks cell entry to protect against infection with inferior effects in B.1.1.7 variant.bioRxiv2021
34006525An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma.Cancer Res2021
33169371Enriched environment enhances NK cell maturation through hypothalamic BDNF in male mice.Eur J Immunol2021
32368735Black raspberries suppress pancreatic cancer through modulation of NKp46<sup>+</sup>, CD8<sup>+</sup>, and CD11b<sup>+</sup> immune cells.Food Front2020
34557678Black raspberries attenuate colonic adenoma development in <i>Apc</i> <sup><i>Min</i></sup> mice: Relationship to hypomethylation of promoters and gene bodies.Food Front2020
32647653Anti-colonic Inflammation by Black Raspberries through Regulating Toll-like Receptor-4 Signaling in Interlukin-10 Knockout Mice.J Cancer Prev2020
30538328The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells.Nat Immunol2019
31861977Fully moderated t-statistic in linear modeling of mixed effects for differential expression analysis.BMC Bioinformatics2019
29800348Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.Nephrol Dial Transplant2019
31547518Rethinking Lupus Nephritis Classification on a Molecular Level.J Clin Med2019
31340937The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector.Cancer Discov2019
30795687The immunomodulatory potential of natural compounds in tumor-bearing mice and humans.Crit Rev Food Sci Nutr2019
29316620Could Aspirin and Diets High in Fiber Act Synergistically to Reduce the Risk of Colon Cancer in Humans?Int J Mol Sci2018
30159104An immunological perspective for preventing cancer with berries.J Berry Res2018
30183689SMAD4 promotes TGF-β-independent NK cell homeostasis and maturation and antitumor immunity.J Clin Invest2018
30097569Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC.Nat Commun2018
30072983A Synthetic Disaccharide Derivative of Diphyllin, TAARD, Activates Human Natural Killer Cells to Secrete Interferon-Gamma <i>via</i> Toll-Like Receptor-Mediated NF-κB and STAT3 Signaling Pathways.Front Immunol2018
29872557The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells.Oncoimmunology2018
30456390Disruption of stromal hedgehog signaling initiates RNF5-mediated proteasomal degradation of PTEN and accelerates pancreatic tumor growth.Life Sci Alliance2018
30479334PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance.Nat Commun2018
30475349An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma.Nat Biotechnol2018
30636993Gut bacteria are required for the benefits of black raspberries in <i>Apc</i> <sup><i>Min/+</i></sup> mice.J Berry Res2018
29524208Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.Int J Cancer2018
29666301Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by <i>Ex Vivo</i>-Expanded Autologous NK Cells.Clin Cancer Res2018
29720575Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation.JCI Insight2018
29769244A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma.Cancer Immunol Res2018
29593706Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a <i>via</i> Targeting the NF-κB Signaling Pathway.Front Immunol2018
29106602PRMT5 as a druggable target for glioblastoma therapy.Neuro Oncol2018
29229679Epigenetic and Posttranscriptional Regulation of CD16 Expression during Human NK Cell Development.J Immunol2018
27866157Loss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice.Carcinogenesis2017
28087981Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.J Gene Med2017
28109960RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.Mol Ther2017
28379437Sex as a biological variable in response to temozolomide.Neuro Oncol2017
28812060Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma.Mol Ther Oncolytics2017
28723548The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.Immunity2017
28718724Black Raspberries and Their Anthocyanin and Fiber Fractions Alter the Composition and Diversity of Gut Microbiota in F-344 Rats.Nutr Cancer2017
28842466IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB.J Immunol2017
28861089Black Raspberries Enhance Natural Killer Cell Infiltration into the Colon and Suppress the Progression of Colorectal Cancer.Front Immunol2017
27852701BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral Therapy.Clin Cancer Res2017
27842222Molecular imaging of the kidney in lupus nephritis to characterize response to treatment.Transl Res2017
28039358Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth.Mol Cancer Res2017
27050072A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.Oncotarget2016
  • 1 - 50 of 90

Recommended Authors

Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 0
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 1
Versiti Blood Research Institute and Medical College of Wisconsin
Career Start Year 2012
Number of shared co-authors 1
Cellworks Group Inc.
Career Start Year 2011
Number of shared co-authors 0
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Nottingham Trent University
Career Start Year 2010
Number of shared co-authors 0
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 1
University of California Los Angeles
Career Start Year 2009
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
The Second Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 2007
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2003
Number of shared co-authors 1
University of California los angeles
Career Start Year 2003
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year 1993
Number of shared co-authors 0
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 3

Collaborators

The Ohio State University
Co-authored papers 10
Co-authored papers 7
the Ohio State University Wexner Medical Center
Co-authored papers 5
The Ohio State University Wexner Medical Center
Co-authored papers 5
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 4
Hospital Fernandez
Co-authored papers 4
Hospital Fernandez
Co-authored papers 4
Co-authored papers 3
Medical College of Georgia
Co-authored papers 3
McGill University
Co-authored papers 3
Baptist Cancer Center
Co-authored papers 2
Statistician in the Department of Emergency Medicine at the University of Cincinnati.
Co-authored papers 1
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 1
Wexner Medical Center, The Ohio State University
Co-authored papers 1
University Health Network
Co-authored papers 1
The University of Texas Health Science Center at San Antonio
Co-authored papers 1
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Co-authored papers 1
University Health Network and University of Toronto
Co-authored papers 1
Co-authored papers 1
The Ohio State University College of Medicine
Co-authored papers 1
Co-authored papers 1
West Virginia University School of Medicine
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Co-authored papers 1
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 1
University Health Network
Co-authored papers 1
Texas Biomedical Research Institute
Co-authored papers 1
Co-authored papers 1